Shirlee Shril

Shirlee Shril

Auto-generated profile, based on publicly available information

Shirlee Shril

Department of Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
AMAmar J. Majmundar
Amar J. Majmundar
FBFlorian Buerger
Florian Buerger
TFThomas Alexander Forbes
Thomas Alexander Forbes
VKVerena Klämbt
Verena Klämbt
RSRonen Schneider
Ronen Schneider
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
NOS1AP variants impair actin remodeling in podocytes and cause glomerular disease in humans, kidney organoids, and mice.

9 February 2022 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
RHReema Habiby
Reema Habiby
DBDaniel G Bichet
Daniel G Bichet
MAMarie-Francoise Arthus
Marie-Francoise Arthus
DCDervia Connaughton
Dervia Connaughton
SSShirlee Shril
Shirlee Shril
GRGary L Robertson
Gary L Robertson
Context: Familial pituitary diabetes insipidus has been described only in an autosomal dominant or recessive mode of inheritance. Objective: This work aims to determine the cause of a novel form of familial diabetes insipidus (DI) that is controlled by desmopressin therapy but segregates in an X-linked recessive manner. Methods: Thirteen members from 3 generations of the kindred with familial DI were studied. Water intake, urine volume, urine osmolality, plasma osmolality, and plasma vasopressin were measured under basal conditions, during fluid deprivation, 3% saline infusion, and water loading. Magnetic resonance images of the posterior pituitary also were obtained. In affected males, the effects of desmopressin therapy and linkage of the DI to markers for chromosome Xq28 were determined. In addition, the genes encoding vasopressin, aquaporin-2, the AVPR2 receptor, and its flanking regions were sequenced. Results: This study showed that 4 males from 3 generations of the kindred have DI that is due to a deficiency of vasopressin, is corrected by standard doses of desmopressin, and segregates with markers for the AVPR2 gene in Xq28. However, no mutations were found in AVPR2 or its highly conserved flanking regions. Exome sequencing confirmed these findings and also revealed no deleterious variants in the provasopressin and aquaporin-2 genes. The 4 obligate female carriers osmo-regulated vasopressin in the low normal range. Conclusion: X-linked recessive transmission of DI can be due to a defect in either the secretion or the action of vasopressin. Other criteria are necessary to differentiate and manage the 2 disorders correctly.